Canada markets closed

Shanghai Pharmaceuticals Holding Co., Ltd (SHPMF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
1.21000.0000 (0.00%)
At close: 02:22PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 8.19B
Enterprise Value 9.84B
Trailing P/E 8.51
Forward P/E 6.69
PEG Ratio (5 yr expected) 1.19
Price/Sales (ttm)0.12
Price/Book (mrq)0.46
Enterprise Value/Revenue 0.04
Enterprise Value/EBITDA 1.14

Trading Information

Stock Price History

Beta (5Y Monthly) 0.25
52-Week Change 3-40.69%
S&P500 52-Week Change 322.38%
52 Week High 32.0400
52 Week Low 31.2100
50-Day Moving Average 31.4044
200-Day Moving Average 31.4842

Share Statistics

Avg Vol (3 month) 31.04k
Avg Vol (10 day) 31.84k
Shares Outstanding 5919.07M
Implied Shares Outstanding 66.77B
Float 81.65B
% Held by Insiders 124.01%
% Held by Institutions 123.94%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.08
Forward Annual Dividend Yield 46.99%
Trailing Annual Dividend Rate 30.41
Trailing Annual Dividend Yield 333.88%
5 Year Average Dividend Yield 4N/A
Payout Ratio 458.80%
Dividend Date 3Aug 21, 2017
Ex-Dividend Date 4Jul 18, 2023
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in CNY.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 1.43%
Operating Margin (ttm)3.39%

Management Effectiveness

Return on Assets (ttm)2.42%
Return on Equity (ttm)6.27%

Income Statement

Revenue (ttm)264.22B
Revenue Per Share (ttm)71.53
Quarterly Revenue Growth (yoy)5.90%
Gross Profit (ttm)N/A
EBITDA 9.51B
Net Income Avi to Common (ttm)3.79B
Diluted EPS (ttm)0.1400
Quarterly Earnings Growth (yoy)1.60%

Balance Sheet

Total Cash (mrq)37.18B
Total Cash Per Share (mrq)10.04
Total Debt (mrq)55.3B
Total Debt/Equity (mrq)67.36%
Current Ratio (mrq)1.34
Book Value Per Share (mrq)18.92

Cash Flow Statement

Operating Cash Flow (ttm)2.38B
Levered Free Cash Flow (ttm)-3.5B